首页> 外文OA文献 >Impact of Oxycodone HCl Extended-release Formulary Restrictions on Extended-release Opioid Market Share, Healthcare Resource Utilization and Costs in Commercial and Medicare Plans

【2h】

Impact of Oxycodone HCl Extended-release Formulary Restrictions on Extended-release Opioid Market Share, Healthcare Resource Utilization and Costs in Commercial and Medicare Plans

机译：羟考酮HCL延长释放的式限制对延长释放的阿片类药物市场份额，医疗资源利用率和商业保健计划的成本的影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Rolin L. Wade; Chi-Chang Chen; Ajita P. De; Jaren C. Howard;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Healthcare Costs And Resource Utilization In Chronic Pain Patients Treated With Extended-Release Formulations Of Tapentadol, Oxycodone, Or Morphine Stratified By Type Of Pain: A Retrospective Claims Analysis, 2012–2016 [J] . Vladimir Zah, Rowe B Brook?eld, Martina Imro, Journal of Pain Research . 2019,第1期

机译：慢性疼痛患者的医疗成本和资源利用，延长释放配方的延长释放制剂，羟考酮或通过疼痛类型分层分层：回顾性要求分析，2012-2016
2. The impact of a reformulation of extended-release oxycodone designed to deter abuse in a sample of prescription opioid abusers [J] . Jennifer R. Havens, Carl G. Leukefeld, Angela M. DeVeaugh-Geiss, Drug and alcohol dependence . 2014,第Null期

机译：旨在阻止处方阿片类药物滥用者滥用的延长释放羟考酮配方的影响
3. Treatment patterns, healthcare resource utilization, and costs among patients with idiopathic pulmonary fibrosis treated with antifibrotic medications in US-based commercial and Medicare Supplemental claims databases: a retrospective cohort study [J] . Mitra Corral, Kathryn DeYoung, Amanda M. Kong BMC Pulmonary Medicine . 2020,第1期

机译：在美国商业和医疗保险补充索赔数据库中抗纤维化药物治疗特发性肺纤维化患者治疗模式，医疗资源利用率和成本：回顾性队列研究
4. Impact of Medicare Part D coverage gap on Medicare beneficiaries with COPD: Adherence, healthcare resource use, and cost. [D] . Yu, Yanni Fan. 2015

机译：Medicare D部分承保范围缺口对患有COPD的Medicare受益人的影响：坚持，医疗资源使用和成本。
5. Healthcare Costs And Resource Utilization In Chronic Pain Patients Treated With Extended-Release Formulations Of Tapentadol Oxycodone Or Morphine Stratified By Type Of Pain: A Retrospective Claims Analysis 2012–2016 [O] . Vladimir Zah, Rowe B Brookﬁeld, Martina Imro, 2019

机译：按疼痛类型分层使用他喷他多羟考酮或吗啡的延长剂量处方治疗的慢性疼痛患者的医疗保健费用和资源利用：回顾性索赔分析2012–2016年
6. Consequences of patient access restrictions to branded oxycodone hydrochloride extended-release tablets on healthcare utilization and costs in US health plans [O] . Rami Ben-Joseph, Chi-Chang Chen, Ajita P. De, 2014

机译：患者访问限制对品牌氧气酮盐酸盐延长释放片剂的后果关于美国健康计划的医疗利用率和成本

Impact of Oxycodone HCl Extended-release Formulary Restrictions on Extended-release Opioid Market Share, Healthcare Resource Utilization and Costs in Commercial and Medicare Plans

著录项

引文网络

相似文献

相关主题

期刊订阅